Lutrelef 3,2 mg, Injektionspräparat

7680473660388 CH-47366 Injektionspräparat
Lutrelef 3,2 mg, Injektionspräparat
Lutrelef 3,2 mg, Injektionspräparat
Lutrelef 3,2 mg, Injektionspräparat
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Injektionspräparat
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
28/07/2022
Summary of Product Characteristics
Français
28/07/2022
Summary of Product Characteristics
Italien
28/07/2022

Detailed composition

Substance Quantity Type Category
SOLV
- Substance HNIDK
PRC
3.2 MG Substance WIZUS
SOLV
35.4 MG Substance HBESI
PRC
2.91 MG Substance Wirkstoff (Principe actif)
SOLV
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK
SOLV
10.0 ML Substance HNIDK

Reimbursement information

Public price
CHF 343.45
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 15/03/1991

Authorization holder

Ferring AG

6340 Baar

Authorization information

Swissmedic authorization number
47366
Drug name
Lutrelef, Injektionspräparat
Galenic form
PULMJ
ATC Code
H01CA01
Authorization status
Z
Dispensing category
B
First authorization
04/08/1986
Authorization expiration date
31/12/9999
IT Number
07.03.1.
Domain
Human medicine
Field of application
Hypothalamische Amenorrhoe, zentraler Hypogonadismus beim Mann

Package details

Description (FR)
LUTRELEF subst sèche 3.2 mg c solv flac
Description (DE)
LUTRELEF Trockensub 3.2 mg c Solv Durchstf
Market launch
04/08/1986
Narcotic (BTM)
No

Other package sizes (1)

LUTRELEF 0.8 sol inj 0.8 mg c solv 10ml fiole
1 DUR
GTIN: 7680473660111
Not in V1